|
|
|
|
U.S. Corporate Ventures Group advises corporate clients seeking to discretely liquidate
non-strategic and impaired direct investments. We thoughtfully determine how to return
maximum value to our clients in consideration of the following:
- which investments to sell individually and which to bundle in a portfolio
- what buyers to approach as likely to appreciate the investment value
- structuring a competitive bidding process
- negotiating effectively to provide maximum returns
Value Added Benefits:
- Realize immediate proceeds from illiquid private and public investments.
Funds may be redirected for strategic purposes.
- Recover approximately 40% of investment losses in the form of tax benefits
- Realize accounting gains at the time of sale
- Clean the balance sheet of previous investment assets held below original cost basis
- Clear the administrative burden, cost and risk of maintaining investments
- Improve the risk profile of the overall portfolio
- Free the investment team to focus on the core investment strategy
U.S. CVG Case Study - Divestitures for a Corporate Strategic Venture Group:
- Managed the divestitures of 15 direct investments with an aggregate original cost basis of $125 million.
- Investments were sold individually to investors with an appreciation for the value returning
greater than projected proceeds
- Realized over $40 million of tax benefits, $35 million which would have otherwise expired
- Identified investors to acquire 40% interest in a public entity triggering a public market
sale of over $50 million
Please reach Michael Seidler or Philip Limeri to discuss how we may help you achieve your objectives.
|
|